5Cabrera Y, Femandez-Guisasola J, Lobo P, et al.Comparison of -ublingnal versus vaginal misoprostol for second trimester pregnancy termination:a meta-analysis. Aust N Z J ObstetGynecol, 2011, 51(2): 158-165.
6Bartlett LA, Berg CJ, Shulman HB, et al. Risk factors for legal induced abortion related mortality in the.United States. ObstetGynecol, 2004, 103: 729-737.
7Jones RK, Kooistra K. Abortion incidence and access to services in the United States, 2008, Perspect Sex Reprod health, 2011, 43: 41-50.
8Khaleel S. Hussaini,Douglas Ritenour,Dean V. Coonrod.Interpregnancy Intervals and the Risk for Infant Mortality: A Case Control Study of Arizona Infants 2003–2007[J].Maternal and Child Health Journal.2013(4)
9Tepper, Naomi K,Curtis, Kathryn M,Jamieson, Denise J,Marchbanks, Polly A.Update to CDC’s U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: Revised Recommendations for the Use of Contraceptive Methods During the Postpartum Period[J].MMWR Morbidity and Mortality Weekly Report.2011(26)
10Ok'ono-fua i~,'Shittu' O, Shochet T, et al. Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria[ J]. Int J Gynecol Obstetric,2014,125 (1) :49-52.
